Linezolid Exposure is Associated with Cytopenias in Patients Treated for Multidrug-Resistant Tuberculosis
Antimicrobial agents and chemotherapy(2022)
摘要
Although linezolid is effective for multidrug-resistant TB (MDR-TB) tuberculosis treatment, it is associated with cytopenias after 4 weeks of administration. Data on toxicities with long-term use of linezolid and drug pharmacodynamics in MDR-TB treatment are limited, and concerns about toxicity present barriers to wider implementation.
更多查看译文
关键词
Mycobacterium tuberculosis,adverse drug effects,cytopenia,linezolid
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要